06.06.2022 - CAMBRIDGE, Mass., June 06, 2022 (GLOBE NEWSWIRE) - Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to ...

Related Keywords

New York , United States , Cambridge , Cambridgeshire , United Kingdom , Randi Isaacs , Company Or Werewolf Nasdaq , Werewolf Therapeutics Inc , , Chief Medical Officer , Jefferies Global Healthcare Conference ,